Literature DB >> 28751560

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

Pietro Bulian1, Riccardo Bomben2, Michele Dal Bo2, Antonella Zucchetto2, Francesca Maria Rossi2, Massimo Degan2, Federico Pozzo2, Tamara Bittolo2, Vanessa Bravin2, Tiziana D'Agaro2, Michaela Cerri3, Annalisa Chiarenza4, Kari G Chaffee5, Adalgisa Condoluci6, Giovanni D'Arena7, Michele Spina8, Francesco Zaja9, Gabriele Pozzato10, Francesco Di Raimondo4, Davide Rossi6, Giovanni Del Poeta11, Gianluca Gaidano3, Tait D Shanafelt5, Valter Gattei2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28751560      PMCID: PMC5664405          DOI: 10.3324/haematol.2017.170340

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.

Authors:  K S Reddy
Journal:  Br J Haematol       Date:  2006-03       Impact factor: 6.998

2.  CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.

Authors:  Antonella Zucchetto; Chiara Caldana; Dania Benedetti; Erika Tissino; Francesca Maria Rossi; Evelyn Hutterer; Federico Pozzo; Riccardo Bomben; Michele Dal Bo; Giovanni D'Arena; Francesco Zaja; Gabriele Pozzato; Francesco Di Raimondo; Tanja N Hartmann; Davide Rossi; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  Blood       Date:  2013-09-25       Impact factor: 22.113

3.  A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.

Authors:  Isabel González-Gascón Y Marín; María Hernández-Sánchez; Ana-Eugenia Rodríguez-Vicente; Carmen Sanzo; Anna Aventín; Anna Puiggros; Rosa Collado; Cecilia Heras; Carolina Muñoz; Julio Delgado; Margarita Ortega; María-Teresa González; Isabel Marugán; Ignacio de la Fuente; Isabel Recio; Francesc Bosch; Blanca Espinet; Marcos González; Jesús-María Hernández-Rivas; José-Ángel Hernández
Journal:  Hematol Oncol       Date:  2015-02-17       Impact factor: 5.271

4.  Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.

Authors:  Paolo Strati; Lynne V Abruzzo; William G Wierda; Susan O'Brien; Alessandra Ferrajoli; Michael J Keating
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-02-11

5.  Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.

Authors:  Monica Messina; Ilaria Del Giudice; Hossein Khiabanian; Davide Rossi; Sabina Chiaretti; Silvia Rasi; Valeria Spina; Antony B Holmes; Marilisa Marinelli; Giulia Fabbri; Alfonso Piciocchi; Francesca R Mauro; Anna Guarini; Gianluca Gaidano; Riccardo Dalla-Favera; Laura Pasqualucci; Raul Rabadan; Robin Foà
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

6.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

7.  CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

Authors:  Pietro Bulian; Tait D Shanafelt; Chris Fegan; Antonella Zucchetto; Lilla Cro; Holger Nückel; Luca Baldini; Antonina V Kurtova; Alessandra Ferrajoli; Jan A Burger; Gianluca Gaidano; Giovanni Del Poeta; Chris Pepper; Davide Rossi; Valter Gattei
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

8.  Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.

Authors:  John C Riches; Conor J O'Donovan; Sarah J Kingdon; Fabienne McClanahan; Andrew J Clear; Donna S Neuberg; Lillian Werner; Carlo M Croce; Alan G Ramsay; Laura Z Rassenti; Thomas J Kipps; John G Gribben
Journal:  Blood       Date:  2014-05-14       Impact factor: 22.113

9.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

10.  The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.

Authors:  Daniel L Van Dyke; Lillian Werner; Laura Z Rassenti; Donna Neuberg; Emanuella Ghia; Nyla A Heerema; Paola Dal Cin; Marie Dell Aquila; Chandrika Sreekantaiah; Andrew W Greaves; Thomas J Kipps; Neil E Kay
Journal:  Br J Haematol       Date:  2016-02-05       Impact factor: 6.998

View more
  5 in total

1.  CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.

Authors:  Erika Tissino; Federico Pozzo; Dania Benedetti; Chiara Caldana; Tamara Bittolo; Francesca Maria Rossi; Riccardo Bomben; Paola Nanni; Hillarj Chivilò; Ilaria Cattarossi; Eva Zaina; Kevin Norris; Jerry Polesel; Massimo Gentile; Giovanni Tripepi; Riccardo Moia; Enrico Santinelli; Idanna Innocenti; Jacopo Olivieri; Giovanni D'Arena; Luca Laurenti; Francesco Zaja; Gabriele Pozzato; Annalisa Chiarenza; Francesco Di Raimondo; Davide Rossi; Chris Pepper; Tanja Nicole Hartmann; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei; Antonella Zucchetto
Journal:  Blood       Date:  2020-04-09       Impact factor: 22.113

2.  New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data.

Authors:  Adrián Mosquera Orgueira; Beatriz Antelo Rodríguez; José Ángel Díaz Arias; Marta Sonia González Pérez; José Luis Bello López
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

3.  KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.

Authors:  Elena Vendramini; Riccardo Bomben; Federico Pozzo; Dania Benedetti; Tamara Bittolo; Francesca Maria Rossi; Michele Dal Bo; Kari G Rabe; Gabriele Pozzato; Francesco Zaja; Annalisa Chiarenza; Francesco Di Raimondo; Esteban Braggio; Sameer A Parikh; Neil E Kay; Tait D Shanafelt; Giovanni Del Poeta; Valter Gattei; Antonella Zucchetto
Journal:  Leukemia       Date:  2019-03-14       Impact factor: 11.528

Review 4.  NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Authors:  Emanuela Rosati; Stefano Baldoni; Filomena De Falco; Beatrice Del Papa; Erica Dorillo; Chiara Rompietti; Elisa Albi; Franca Falzetti; Mauro Di Ianni; Paolo Sportoletti
Journal:  Front Oncol       Date:  2018-06-27       Impact factor: 6.244

5.  A large fraction of trisomy 12, 17p-, and 11q- CLL cases carry unidentified microdeletions of miR-15a/16-1.

Authors:  Felice Pepe; Laura Z Rassenti; Yuri Pekarsky; Jadwiga Labanowska; Tatsuya Nakamura; Giovanni Nigita; Thomas J Kipps; Veronica Balatti; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 12.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.